Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Mar 16, 2022; 10(8): 2429-2438
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2429
Table 3 Multivariate analysis of progression-free survival and overall survival in 51 patients with metastatic colorectal cancer treated with triplet therapy

PFS
OS
HR (95%CI)
P value
HR (95%CI)
P value
Age0.002
≥ 651a
< 650.22 (0.08-0.57)
Liver metastasis0.0760.003
Yes1a1a
No0.5 (0.23-1.07)0.21 (0.07-0.6)
Metastasectomy0.0010.005
Yes1a1a
No0.23 (0.09-0.57)0.18 (0.05-0.61)